scispace - formally typeset
J

Jacqueline K. Barton

Researcher at California Institute of Technology

Publications -  430
Citations -  45235

Jacqueline K. Barton is an academic researcher from California Institute of Technology. The author has contributed to research in topics: DNA & Base pair. The author has an hindex of 100, co-authored 429 publications receiving 43349 citations. Previous affiliations of Jacqueline K. Barton include City University of New York & University of North Carolina at Chapel Hill.

Papers
More filters
Journal ArticleDOI

The Effect of Varied Ion Distributions on Long-Range DNA Charge Transport

TL;DR: The longitudinal polarizability of DNA may be important to consider in mechanisms for long-range DNA charge transport, as high values for the internal dielectric constant of the stacked base pairs are suggested by data.
Journal ArticleDOI

Synthesis and spectroscopic characterization of the purple tris(phenanthrenequinone diimine)ruthenium(II) ion

TL;DR: In this article, the ground and excited-state electronic structures of bipyridyl and phenanthroline diimine complexes of ruthenium(II) have been characterized.
Patent

Mixed ligand complexes and uses thereof as binding agents and probes to DNA

TL;DR: In this article, a coordination complex or salt thereof which is spectroscopically or photoactively determinable when bound to DNA having the formula ##STR1## was proposed. But the coordination complex was not shown to be photoactively determined.
Journal ArticleDOI

A Versatile Synthetic Approach to Rhodium(III) Diimine Metallointercalators: Condensation of o-Quinones with Coordinated cis-Ammines

TL;DR: In this article, a new route to the preparation of rhodium(III) diimine complexes which bind DNA by intercalation was developed by condensation of coordinated ammine ligands with o-quinones.
Patent

Site-specific chiral ruthenium (II) and cobalt (III) antitumor agents

TL;DR: In this article, a coordination complex of the formula (R 2 --M--(Y) 2 is proposed for DNA labeling with coordination bonds, and a pharmaceutical composition for the treatment of tumor cells in a subject is prepared containing an effective anti-tumor amount of a complex of this invention and a pharmaceutically acceptable carrier.